Pharma Pulse 11/29/24: AI’s Role in Personalizing Life Sciences Digital Experiences & more

AI’s Role in Personalizing Life Sciences Digital Experiences

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chase Feiger, MD, co-founder, Ostro, discusses the value of AI technology when it comes to tackling digital commercialization challenges.

COVID-19 Incidence Among Children Not Related to Elementary School Attendance

Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.

Should You Still Learn to Code in an A.I. World?

Coding boot camps once looked like the golden ticket to an economically secure future. But as that promise fades, what should you do? Keep learning, until further notice.

U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for RapiblykTM (landiolol) in the hospital critical care setting for the treatment of the severe heart condition supraventricular tachycardia (atrial fibrillation and atrial flutter). The approval is based on clinical studies which demonstrated that RapiblykTM (landiolol) enables rapid management of the heart rate with minimal reduction of blood pressure. The approval will provide patients in the U.S. with a new treatment option and is an important step for AOP Health in bringing its mission to help patients and make an impact on rare diseases and critical care to the United States for the first time.

Pharmaceutical Executive on LinkedIn

Happy Thanksgiving to all of our readers, listeners, experts, and clients! We're so thankful for all of the voices that help Pharmaceutical Executive be an authority in the pharma industry.
Looking forward to finishing out 2024 strong, and preparing to hit the ground running in 2025!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs